remdesivir in A Sentence

    1

    Remdesivir appears to be the most promising.

    0
    2

    Remdesivir is a novel antiviral drug developed

    0
    3

    Later, Remdesivir also demonstrated possible inhibition of other

    0
    4

    Remdesivir was created

    0
    5

    Clinical improvement was observed in patients treated with compassionate-use Remdesivir.

    0
    6

    Interestingly, the nucleotide analogue Remdesivir is known to suppress CoV replication

    0
    7

    Remdesivir is one of most promising anti-SARS-CoV-2 agents to be tested in clinical trials.

    0
    8

    Later, Remdesivir also demonstrated possible inhibition of other single stranded RNA viruses including MERS and SARS viruses.

    0
    9

    Remdesivir is a novel antiviral drug developed by Gilead initially for the treatment of diseases caused by Ebola and Marlburg viruses.

    0
    10

    Interestingly, the nucleotide analogue Remdesivir is known to suppress CoV replication through inhibition of this exoribonuclease and the RNA-dependent RNA polymerase.

    0
    11

    Repurposed antiviral drugs make up most of the Chinese research, with 9 Phase III trials on Remdesivir across several countries due to report by the end of April.

    0
    12

    Repurposed antiviral drugs make up most of the Chinese research, with nine phase III trials on Remdesivir across several countries due to report by the end of April.

    0
    13

    Remdesivir was created and developed by Gilead Sciences as a treatment for Ebola virus disease and Marburg virus infections. Gilead Sciences subsequently discovered that Remdesivir had antiviral activity in vitro against multiple filo-, pneumo-, paramyxo-, and corona- viruses.

    0
    14

    Some early pretrial studies suggest Remdesivir may have a high genetic barrier to resistance. There are several clinical trials underway, including two conducted by Cleveland University Hospitals; one for people with moderate illness and another for those with more severe illness.

    0
    15

    A dynamic review of clinical development for COVID-19 vaccine and drug candidates was in place, as of April 2020. Several existing antiviral medications are being evaluated for treatment of COVID-19, including Remdesivir, chloroquine and hydroxychloroquine, lopinavir/ritonavir and lopinavir/ritonavir combined with interferon beta.

    0